In Vivo Toxicology Market worth 6.14 Billion USD by 2022


Posted April 23, 2018 by goremaheshr

The report "In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits))

 
The report "In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility (Outsourced, In-house) - Global Forecast to 2022", The in vivo toxicology market is expected to reach USD 6.14 Billion by 2022 from an estimated USD 4.40 Billion in 2017, at a CAGR of 6.9%. The key factors driving the growth of this market include increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests.

Browse 124 tables and 38 figures spread through 196 pages and in-depth TOC on "In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility (Outsourced, In-house) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/in-vivo-toxicology-testing-market-105308811.html
Early buyers will receive 10% customization on reports.

The consumables segment is expected to hold the largest share of the market

Based on product, the in vivo toxicology market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models. In 2017, the consumables segment is expected to account for the largest share of the in vivo toxicology market owing to the increasing R&D funding for the development of new transgenic animal models, advancements in the development of genetically modified animals, increasing usage of reagents and kits for biological sample analysis.

By testing type, sub-acute toxicity testing to register the highest CAGR during the forecast period

The in vivo toxicology market is segmented by testing type into chronic, sub-chronic, sub-acute, and acute toxicology testing. In 2017, the sub-acute toxicity testing segment is expected to register the highest CAGR of during the forecast period. Growth in this market is attributed to the increasing focus on neurological and anti-viral drug research, which requires more than two weeks of toxicity studies.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mahesh
Country United States
Categories Advertising
Tags In Vivo Toxicology Market , In Vivo Toxicology
Last Updated April 23, 2018